Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis - Quiz - MDSpire

Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis

  • By

  • Noha M. Bakr

  • Noha A. Hashim

  • Mohamed Adel El-Eshmawy

  • Hatim A. El-Baz

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis

  • by Noha M. Bakr, Noha A. Hashim, Mohamed Adel El-Eshmawy, Hatim A. El-Baz

  • May 25, 2026

Related Content

A combined therapeutic approach: extracorporeal shock wave therapy and botulinum toxin in multiple sclerosis-related spasticity

Global overview of multiple sclerosis care units: an international cross-sectional survey

The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions